Search clinical trials for: Ofatumumab and Bortezomib
Total 272705 results
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Novartis PharmaceuticalsNot yet recruiting
-
Genentech, Inc.Seagen Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Active, not recruitingMantle Cell LymphomaUnited States
-
Janssen-Cilag International NVCompleted
-
Zhongnan HospitalRecruitingAcute Myeloid Leukemia | BortezomibChina
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisJapan, Russian Federation
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedColorectal CancerCanada
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineWithdrawnLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, B-Cell, Marginal Zone | Lymphoma, Low-Grade | Lymphoma, Intermediate-Grade
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...TerminatedMyelodysplastic SyndromeUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
University of Southern CaliforniaNovartis PharmaceuticalsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsActive, not recruiting
-
Grupo Espanol de trasplantes hematopoyeticos y...GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsCompletedLeukaemiaBelgium, Austria, Czechia, France, Germany, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Ireland, Italy, Slovakia, Bulgaria, Singapore, Ukraine, Poland
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineWithdrawnLymphoma, FollicularUnited States
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicSpain, United States, Belgium, India, United Kingdom, Netherlands, Czechia, Germany, Greece, Italy, Russian Federation, Sweden, Canada, Ireland, Poland, France, Brazil
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
European Organisation for Research and Treatment...CompletedMalignant MesotheliomaUnited Kingdom
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicJapan
-
University of NebraskaGlaxoSmithKline; Celgene CorporationCompletedNon-Hodgkin's LymphomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia and other conditionsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMantle Cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
University of Kansas Medical CenterMillennium Pharmaceuticals, Inc.CompletedAutologous Transplant | Malignant Lymphoma, Stem Cell TypeUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis, Relapsing-Remitting
-
GlaxoSmithKlineGenmabCompletedLeukaemia, Lymphocytic, ChronicSweden
-
Scios, Inc.Completed
-
Scios, Inc.Completed
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
Cancer Trials IrelandCompletedMalignant MesotheliomaUnited Kingdom, Ireland, Belgium, Netherlands
-
University of BolognaJanssen-Cilag Ltd.Unknown
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Virginia Commonwealth UniversityCompletedMelanoma | Soft Tissue Sarcoma | Parathyroid Carcinoma | Small Cell Carcinoma of the Lung | Carcinoid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States